Johnson & Johnson
(NYSE:JNJ)
$
259.33
-3.71 (-1.41%)
Market Cap: 624.26 Bil
Enterprise Value: 657.20 Bil
PE Ratio: 29.98
PB Ratio: 7.69
GF Score: 81/100 Johnson & Johnson at JPMorgan Healthcare Conference Transcript
Jan 12, 2026 / 04:15PM GMT
Release Date Price:
$209.72
(+2.61%)
Christopher Schott
JPMorgan Chase & Co - Analyst
Good morning. I'm Chris Schott from J.P. Morgan. And it's my pleasure to be hosting this fireside discussion with Joaquin Duato, the Chairman and CEO of J&J. Joaquin, happy new year.
Questions & Answers
Joaquin Duato
Johnson & Johnson - Chairman of the Board, Chief Executive Officer
Thank you.
Christopher Schott
JPMorgan Chase & Co - Analyst
Great speaking with you today. Can we just open up the conversation? We're coming off of a year with significant outperformance for the stock, some really impressive underlying fundamentals. We'd love just to hear about your top priorities for the company as we enter 2026.
Joaquin Duato
Johnson & Johnson - Chairman of the Board, Chief Executive Officer
Thank you. So first, thank you for organizing this impressive meeting. Every year, J.P. Morgan does a very good job in bringing us all together and kicking off the year. So thank you for doing that. And
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot